home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Managing GLP Studies in Non-GLP Facilities - Webinar By ComplianceOnline

 
  May 22, 2012  
     
 
ComplianceOnline, Online Webinar
2012-07-06


Why Should You Attend:

An increasing number of companies and universities are running GLP studies or study phases in facilities that have never before been part of a regulated environment. Performing a GLP study in a non-GLP facility presents special challenges. If these challenges are not addressed properly, parts of a study might be non-compliant, increasing the risk of study rejection. This presentation describes the obvious challenges in running GLP studies in labs where non-GLP and other unrelated experimentation occurs. It offers tips on how to manage and separate GLP activities from non-GLP activities.

This webinar begins by clarifying what constitutes a GLP study. It explains where development work ends and GLP regulations begin. It describes the important transition between new drug development, which is not governed by regulations, and safety testing, which is in the scope of GLP. The presenter gives tips on good recordkeeping for the synthesis methods used in new drug development. The discussion also describes the risks of not understanding the GLP/non-GLP distinction. It describes the challenges of running regulated studies in the same lab as basic research. Special examples in equipment use, reagents, reference standards, and storage units are discussed.

Areas Covered in the Seminar:

  • What constitutes a GLP study?
  • What are the biggest risks in mixing GLP and non-GLP work in the same facility?
  • How to separate GLP from non-GLP reagents
  • How to keep test articles and reference standards away from non-GLP
  • How to divide labs into GLP and non-GLP zones
  • How to identify testing facility management
  • How to train graduate students, interns, etc., in GLP
  • What goes into the compliance statement when non-GLP activities are part of a GLP study?

 

 
 
Organized by: ComplianceOnline
Invited Speakers: Anne Maczulak, PhD, RQAP-GLP, is an independent consultant at Acorn GLP Consulting. She has more than 20 years experience as sponsor, study director, or participating scientist in preclinical studies. Anne works with established companies, startups, and universities in need of guidance in GLP regulations.
 
Deadline for Abstracts: 2012-07-06
 
Registration:
For Registration:
 
E-mail: referral@complianceonline.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.